Amplified Sciences Earns CLIA Certification for Its First Test to Assess Pancreatic Cancer Risk
Purdue University
Company to commercialize PanCystPro, including establishing an early access program and completing a clinical utility trial in 2025
Pancreatic Cancer
New Research Suggests How to Improve Effectiveness of KRAS Inhibitors in Pancreatic Cancer
Memorial Sloan Kettering Cancer Center
New research in mouse models has uncovered a new mechanism of resistance to KRAS inhibitors
New Hope for Early Detection and Prevention of Pancreatic Cancer
National Comprehensive Cancer Network
New findings suggest pathway for screening high-risk individuals for pancreatic cancer in PRECEDE study
Novel Exosome-Based Liquid Biopsy Detects Pancreatic Cancer
American Association for Cancer Research
When combined with CA 19-9, the novel biopsy accurately detected 97 percent of stage 1–2 pancreatic cancers
Vaccine Candidate Delays Relapse of KRAS-Mutated Cancers
University of Texas MD Anderson Cancer Center
All patients receiving the highest dose had significant T-cell responses, correlating with a significant reduction in risk of relapse
What’s New in Histology?
Michael Schubert, PhD
Recent news from the world of tissue-based diagnostics
Treatment-Trio Shows Promise in Patients with Pancreatic Cancers
John Hopkins Medicine
Combination therapy improved median disease-free and overall survival in pancreatic ductal adenocarcinoma cases
Pancreatic Lesions May Occur Earlier than Previously Thought
American Association for Cancer Research
Researchers partnered with Gift Of Life Michigan to analyze healthy pancreata from deceased donors
NIH Releases Annual Report to the Nation
National Institutes of Health
Cancer deaths continue downward trend; modest improvements in survival for pancreatic cancer
New Guidelines for Pancreatic Cancer Screening
Beth Israel Deaconess Medical Center
The new guidelines expand indication for screening for all with the gene variations regardless of family history